Urine Is an Ideal Biomarker Resource in Early Detecting Neurodegenerative Diseases
Publisher
Springer Singapore
Reference66 articles.
1. Alessenko AV, AEBaLBD. Connection of lipid peroxide oxidation with the sphingomyelin pathway in the development of Alzheimer’s disease. Biochem Soc Trans. 2004;32(1):144–6.
2. Almeida-Santos AF, Kangussu LM, Campagnole-Santos MJ. The renin-angiotensin system and the neurodegenerative diseases: a brief review. Protein Pept Lett. 2017;24(9):841–53. https://doi.org/10.2174/0929866524666170822120258 .
3. Amor S, Peferoen LA, Vogel DY, Breur M, van der Valk P, Baker D, van Noort JM. Inflammation in neurodegenerative diseases–an update. Immunology. 2014;142(2):151–66. https://doi.org/10.1111/imm.12233 .
4. Ben-Nun A, Kaushansky N, Kawakami N, Krishnamoorthy G, Berer K, Liblau R, Hohlfeld R, Wekerle H. From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development. J Autoimmun. 2014;54:33–50. https://doi.org/10.1016/j.jaut.2014.06.004 .
5. Bonardi C, de Pulford F, Jennings D, Pardon MC. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer’s disease. Behav Brain Res. 2011;222(1):89–97. https://doi.org/10.1016/j.bbr.2011.03.041 .